Proof of Concept Study on BP1.4979 Effect on Primary Premature Ejaculation — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Proof of Concept Study on BP1.4979 Effect on Primary Premature Ejaculation — Stella

Home/Premature (Early) Ejaculation/

View on ClinicalTrials.gov

Recruiting

Back to Premature (Early) Ejaculation trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

France

University Hospital of Nîmes, Nîmes

Key details

Phase

Safety & dosing

Sponsor

Bioprojet

Enrollment target

~60 participants

Started

September 2025

Primary completion

December 2026

Age range

18 Years – 50 Years

Sex

Male only

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

Last updated October 2025